Logo image of CLPS

CLPS INC (CLPS) Stock Fundamental Analysis

NASDAQ:CLPS - Nasdaq - KYG316421042 - Common Stock - Currency: USD

0.95  -0.01 (-1.04%)

Fundamental Rating

2

Taking everything into account, CLPS scores 2 out of 10 in our fundamental rating. CLPS was compared to 82 industry peers in the IT Services industry. Both the profitability and financial health of CLPS have multiple concerns. CLPS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLPS has reported negative net income.
Of the past 5 years CLPS 4 years were profitable.
CLPS had a positive operating cash flow in 4 of the past 5 years.
CLPS Yearly Net Income VS EBIT VS OCF VS FCFCLPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

CLPS has a Return On Assets of -1.03%. This is comparable to the rest of the industry: CLPS outperforms 42.68% of its industry peers.
The Return On Equity of CLPS (-2.02%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.03%
ROE -2.02%
ROIC N/A
ROA(3y)0.84%
ROA(5y)3.42%
ROE(3y)1.12%
ROE(5y)5.2%
ROIC(3y)N/A
ROIC(5y)N/A
CLPS Yearly ROA, ROE, ROICCLPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

Looking at the Gross Margin, with a value of 23.38%, CLPS is doing worse than 74.39% of the companies in the same industry.
In the last couple of years the Gross Margin of CLPS has declined.
CLPS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.21%
GM growth 5Y-8.85%
CLPS Yearly Profit, Operating, Gross MarginsCLPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

CLPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLPS has more shares outstanding
Compared to 5 years ago, CLPS has more shares outstanding
The debt/assets ratio for CLPS is higher compared to a year ago.
CLPS Yearly Shares OutstandingCLPS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CLPS Yearly Total Debt VS Total AssetsCLPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

CLPS has an Altman-Z score of 1.96. This is not the best score and indicates that CLPS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, CLPS is doing worse than 63.41% of the companies in the same industry.
CLPS has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CLPS (0.46) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 1.96
ROIC/WACCN/A
WACC8.12%
CLPS Yearly LT Debt VS Equity VS FCFCLPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

CLPS has a Current Ratio of 1.74. This is a normal value and indicates that CLPS is financially healthy and should not expect problems in meeting its short term obligations.
CLPS's Current ratio of 1.74 is in line compared to the rest of the industry. CLPS outperforms 56.10% of its industry peers.
A Quick Ratio of 1.74 indicates that CLPS should not have too much problems paying its short term obligations.
CLPS has a Quick ratio (1.74) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
CLPS Yearly Current Assets VS Current LiabilitesCLPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

CLPS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.64%, which is quite impressive.
Looking at the last year, CLPS shows a small growth in Revenue. The Revenue has grown by 5.93% in the last year.
CLPS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.12% yearly.
EPS 1Y (TTM)63.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y4.28%
Revenue growth 5Y17.12%
Sales Q2Q%15.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLPS Yearly Revenue VS EstimatesCLPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CLPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLPS Price Earnings VS Forward Price EarningsCLPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLPS Per share dataCLPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.54%, CLPS is a good candidate for dividend investing.
The stock price of CLPS dropped by -21.54% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.52, CLPS pays a better dividend. On top of this CLPS pays more dividend than 100.00% of the companies listed in the same industry.
CLPS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 13.54%

5.2 History

CLPS has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
CLPS Yearly Dividends per shareCLPS Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
CLPS Yearly Income VS Free CF VS DividendCLPS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

More info and screens

CLPS INC

NASDAQ:CLPS (6/10/2025, 1:14:28 PM)

0.95

-0.01 (-1.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-05 2025-03-05
Earnings (Next)10-16 2025-10-16
Inst Owners0.47%
Inst Owner Change-67.35%
Ins Owners21.52%
Ins Owner ChangeN/A
Market Cap26.59M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield 13.54%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.5
BVpS2.14
TBVpS2.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.03%
ROE -2.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.38%
FCFM N/A
ROA(3y)0.84%
ROA(5y)3.42%
ROE(3y)1.12%
ROE(5y)5.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.21%
GM growth 5Y-8.85%
F-ScoreN/A
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 1.96
F-ScoreN/A
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)831.18%
Cap/Depr(5y)538.27%
Cap/Sales(3y)5.16%
Cap/Sales(5y)3.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.93%
Revenue growth 3Y4.28%
Revenue growth 5Y17.12%
Sales Q2Q%15.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-868.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.03%
OCF growth 3YN/A
OCF growth 5Y86.11%